F-group (family)
5.1.4.256 WD40, eIF2A, Beta-prop_WDR5
Ligands and drugs
297
Member domains
138
with ligand contacts (≤ 4 Å)
46.5% of members
126
with DrugDomain annotations
42.4% of members
54
with a DrugBank compound
18.2% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 5.1.4.256 belongs to X-group 5 beta-propeller-like, which binds 7.8 ligand superclasses per 20 proteins, broader than 52% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB08839 | SRO | Serotonin | 2 |
| DB00125 | ARG | Arginine | 1 |
| DB02302 | 2MR | Symmetric dimethylarginine | 1 |
| DB11815 | NMM | Tilarginine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| UNX | UNKNOWN ATOM OR ION | 20 |
| CL | CHLORIDE ION | 13 |
| NP7 | 2-chloro-N-[2-(4-methylpiperazin-1-yl)-5-nitrophenyl]benzamide | 4 |
| OGY | [2-(3-phenylpropyl)-1H-imidazol-4-yl]methanol | 4 |
| SCN | THIOCYANATE ION | 3 |
| 0BW | methyl 3-[(3-methoxybenzoyl)amino]-4-(4-methylpiperazin-1-yl)benzoate | 2 |
| 35Q | N-(4-(4-methylpiperazin-1-yl)-3'-(morpholinomethyl)-[1,1'-biphenyl]-3-yl)-6-oxo-4-(trifluoromethyl)-1,6-dihydropyridine-3-carboxamide | 2 |
| 5ML | 3-methyl-~{N}-[2-(4-methylpiperazin-1-yl)-5-quinolin-3-yl-phenyl]benzamide | 2 |
| 5MN | ~{N}-[5-(1~{H}-indol-5-yl)-2-(4-methylpiperazin-1-yl)phenyl]-3-methyl-benzamide | 2 |
| 5MQ | N-[5-(2,3-dihydro-1-benzofuran-7-yl)-2-(4-methylpiperazin-1-yl)phenyl]-3-methylbenzamide | 2 |
| A1A16 | (3P)-N-[(2S)-1-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)-1-oxopentan-2-yl]-3-[1-ethyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-5-[(1H-imidazol-1-yl)methyl]benzamide | 2 |
| BEN | BENZAMIDINE | 2 |
| G2D | N-[(1R)-6-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-2-yl)-2,3-dihydro-1H-inden-1-yl]-3-methoxy-4-methylbenzamide | 2 |
| HLJ | N-[(3,4-dichlorophenyl)methyl]-3-(6-fluoro-2-methylpyridin-3-yl)-5-{[(2E)-2-imino-3-methyl-2,3-dihydro-1H-imidazol-1-yl]methyl}benzamide | 2 |
| HLM | N-[(1S)-1-(3-chlorophenyl)ethyl]-3-{[(4,5-dihydro-1H-imidazol-2-yl)amino]methyl}benzamide | 2 |
| HLP | 5-[(1H-imidazol-1-yl)methyl]furan-2-carboxylic acid | 2 |
| HLS | 3-{[(4,5-dihydro-1H-imidazol-2-yl)amino]methyl}-N-[(3,5-dimethoxyphenyl)methyl]-4-fluorobenzamide | 2 |
| MBU | (5P)-2-[(S)-cyclopropyl(4-methylpyridin-2-yl)methyl]-5-[1-ethyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-7-[(2-methyl-1H-imidazol-1-yl)methyl]-3,4-dihydroisoquinolin-1(2H)-one | 2 |
| NAmetal | SODIUM ION | 2 |
| OH1 | N-{4-[4-(hydroxymethyl)-1H-imidazol-2-yl]butyl}benzamide | 2 |